Christian Fischer, Nynke A Vepřek, Zisis Peitsinis, Klaus-Peter Rühmann, Chao Yang, Jessica N Spradlin, Dustin Dovala, Daniel K Nomura, Yingkai Zhang, Dirk Trauner
The COVID-19 pandemic prompted many scientists to investigate remedies against SARS-CoV-2 and related viruses that are likely to appear in the future. As the main protease of the virus, MPro , is highly conserved among coronaviruses, it has emerged as a prime target for developing inhibitors. Using a combination of virtual screening and molecular modeling, we identified small molecules that were easily accessible and could be quickly diversified. Biochemical assays confirmed a class of pyridones as low micromolar non-covalent inhibitors of the viral main protease...
August 2021: Synlett: Accounts and Rapid Communications in Synthetic Organic Chemistry